Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Most users notice reduced shedding within the first month
Certain conditions (personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2) contraindicate GLP-1 use, which is why medical evaluation is essential and built into PlexusDx's process
Session Information Date: Sunday, October 26, 2025 Title: (04300469) Rheumatoid Arthritis Diagnosis, Manifestations, and Outcomes Poster I Session Type: Poster Session A Session Time: 10:30AM-12:30PM Background/Purpose: Obesity significantly increases cardiovascular morbidity and mortality in rheumatoid arthritis (RA), yet effective strategies for managing obesity-related risks in this population remain limited
The only safe and legitimate route to access it is through participation in an approved research study, such as those listed on the NIHR 'Be Part of Research' service
